#24. Communication with the physician managing ongoing care post-fracture
|
#39. Screening or therapy for osteoporosis for women aged 65 years and older
|
#40. Management following fracture
|
#41. Pharmacologic therapy
|
#108. Disease modifying anti-rheumatic drug therapy in rheumatoid arthritis
|
#109. Patients with osteoarthritis who have an assessment of their pain and function
|
#124. Adoption/use of health information technology (electronic health records)
|
#131. Pain assessment prior to initiation of patient therapy and follow-up
|
#142. Assessment for use of anti-inflammatory or analgesic over-the-counter (OTC) medications
|
#154. Risk assessment
|
#176. Tuberculosis screening
|
#177. Periodic assessment of disease activity
|
#178. Functional status assessment
|
#179. Assessment and classification of disease prognosis
|
#180. Glucocorticoid management
|
|
Quality Measures Group: Back Pain
- #148. Initial Visit
- #149. Physical Exam
- #150. Advice for Normal Activities
- #151. Advice Against Bed Rest
|
Quality Measures Group: Rheumatoid Arthritis
- #108. Disease modifying anti-rheumatic drug therapy (DMARD)
- #176. Tuberculosis screening
- #177. Periodic assessment of disease activity
- #178. Functional status assessment
- #179. Assessment and classification of disease prognosis
- #180. Glucocorticoid management
|